Entia Biosciences Inc (ERGO)
0.0002
0.00 (0.00%)
USD |
OTCM |
Nov 12, 16:00
Entia Biosciences EPS Diluted (Quarterly): -0.02 for Dec. 31, 2016
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2016 | -0.02 |
| September 30, 2016 | -0.01 |
| June 30, 2016 | -0.01 |
| March 31, 2016 | -0.01 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -0.01 |
| June 30, 2015 | -0.05 |
| March 31, 2015 | -0.05 |
| December 31, 2014 | -0.06 |
| September 30, 2014 | -0.06 |
| June 30, 2014 | -0.06 |
| March 31, 2014 | -0.06 |
| December 31, 2013 | -0.14 |
| September 30, 2013 | -0.07 |
| June 30, 2013 | -0.14 |
| March 31, 2013 | -0.06 |
| December 31, 2012 | -0.04 |
| September 30, 2012 | -0.04 |
| Date | Value |
|---|---|
| June 30, 2012 | -0.05 |
| March 31, 2012 | -0.04 |
| December 31, 2011 | -0.10 |
| September 30, 2011 | -0.03 |
| June 30, 2011 | -0.03 |
| March 31, 2011 | -0.11 |
| December 31, 2010 | -0.04 |
| September 30, 2010 | -0.10 |
| June 30, 2010 | -0.10 |
| March 31, 2010 | -0.10 |
| December 31, 2009 | -0.10 |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | -0.0192 |
| September 30, 2008 | 0.00 |
| July 31, 2008 | -0.0009 |
| April 30, 2008 | 0.00 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ampio Pharmaceuticals Inc | -2.48 |
| FluoroPharma Medical Inc | -0.01 |
| Evolutionary Genomics Inc | -0.06 |
| Xeno Transplants Corp | -- |
| Regenerx Biopharmaceuticals Inc | -0.2683 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.4328M |
| Revenue (Quarterly) | 0.046M |
| Total Expenses (Quarterly) | 0.4316M |